Liang S[au] - Search Results

Year	Number of Results
1947	1
1948	1
1957	2
1958	4
1959	2
1960	1
1963	2
1970	1
1973	1
1976	2
1977	3
1979	2
1980	6
1981	5
1982	5
1983	6
1984	7
1985	15
1986	12
1987	12
1988	13
1989	11
1990	12
1991	13
1992	17
1993	22
1994	19
1995	19
1996	13
1997	27
1998	22
1999	32
2000	42
2001	43
2002	55
2003	60
2004	70
2005	84
2006	106
2007	135
2008	190
2009	178
2010	212
2011	252
2012	304
2013	366
2014	437
2015	436
2016	481
2017	509
2018	622
2019	729
2020	867
2021	968
2022	676

1

Clinical update on COVID-19 for the emergency clinician: Presentation and evaluation.

Long B, Carius BM, Chavez S, Liang SY, Brady WJ, Koyfman A, Gottlieb M. Long B, et al. Among authors: liang sy. Am J Emerg Med. 2022 Apr;54:46-57. doi: 10.1016/j.ajem.2022.01.028. Epub 2022 Jan 21. Am J Emerg Med. 2022. PMID: 35121478 Free PMC article. Review.

2

Chemical-induced chromatin remodeling reprograms mouse ESCs to totipotent-like stem cells.

Yang M, Yu H, Yu X, Liang S, Hu Y, Luo Y, Izsvák Z, Sun C, Wang J. Yang M, et al. Among authors: liang s. Cell Stem Cell. 2022 Mar 3;29(3):400-418.e13. doi: 10.1016/j.stem.2022.01.010. Epub 2022 Feb 9. Cell Stem Cell. 2022. PMID: 35143761

3

[Retracted] miR‑663 promotes NPC cell proliferation by directly targeting CDKN2A.

Liang S, Zhang N, Deng Y, Chen L, Zhang Y, Zheng Z, Luo W, Lv Z, Li S, Xu T. Liang S, et al. Mol Med Rep. 2022 Jan;25(1):23. doi: 10.3892/mmr.2021.12539. Epub 2021 Nov 23. Mol Med Rep. 2022. PMID: 34812473 Free PMC article.

4

Mitolysosome exocytosis, a mitophagy-independent mitochondrial quality control in flunarizine-induced parkinsonism-like symptoms.

Bao F, Zhou L, Zhou R, Huang Q, Chen J, Zeng S, Wu Y, Yang L, Qian S, Wang M, He X, Liang S, Qi J, Xiang G, Long Q, Guo J, Ying Z, Zhou Y, Zhao Q, Zhang J, Zhang D, Sun W, Gao M, Wu H, Zhao Y, Nie J, Li M, Chen Q, Chen J, Zhang X, Pan G, Zhang H, Li M, Tian M, Liu X. Bao F, et al. Among authors: liang s. Sci Adv. 2022 Apr 15;8(15):eabk2376. doi: 10.1126/sciadv.abk2376. Epub 2022 Apr 13. Sci Adv. 2022. PMID: 35417232 Free PMC article.

5

Proteomic and metabolomic profiling of urine uncovers immune responses in patients with COVID-19.

Bi X, Liu W, Ding X, Liang S, Zheng Y, Zhu X, Quan S, Yi X, Xiang N, Du J, Lyu H, Yu D, Zhang C, Xu L, Ge W, Zhan X, He J, Xiong Z, Zhang S, Li Y, Xu P, Zhu G, Wang D, Zhu H, Chen S, Li J, Zhao H, Zhu Y, Liu H, Xu J, Shen B, Guo T. Bi X, et al. Among authors: liang s. Cell Rep. 2022 Jan 18;38(3):110271. doi: 10.1016/j.celrep.2021.110271. Epub 2021 Dec 28. Cell Rep. 2022. PMID: 35026155 Free PMC article.

6

A split prime editor with untethered reverse transcriptase and circular RNA template.

Liu B, Dong X, Cheng H, Zheng C, Chen Z, Rodríguez TC, Liang SQ, Xue W, Sontheimer EJ. Liu B, et al. Among authors: liang sq. Nat Biotechnol. 2022 Apr 4. doi: 10.1038/s41587-022-01255-9. Online ahead of print. Nat Biotechnol. 2022. PMID: 35379962

7

ROS/PI3K/Akt and Wnt/β-catenin signalings activate HIF-1α-induced metabolic reprogramming to impart 5-fluorouracil resistance in colorectal cancer.

Dong S, Liang S, Cheng Z, Zhang X, Luo L, Li L, Zhang W, Li S, Xu Q, Zhong M, Zhu J, Zhang G, Hu S. Dong S, et al. Among authors: liang s. J Exp Clin Cancer Res. 2022 Jan 8;41(1):15. doi: 10.1186/s13046-021-02229-6. J Exp Clin Cancer Res. 2022. PMID: 34998404 Free PMC article.

8

Cell Cycle Dysregulation and Renal Fibrosis.

Wu YS, Liang S, Li DY, Wen JH, Tang JX, Liu HF. Wu YS, et al. Among authors: liang s. Front Cell Dev Biol. 2021 Nov 25;9:714320. doi: 10.3389/fcell.2021.714320. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34900982 Free PMC article. Review.

9

Optimization of Nanoparticles for Smart Drug Delivery: A Review.

Jia L, Zhang P, Sun H, Dai Y, Liang S, Bai X, Feng L. Jia L, et al. Among authors: liang s. Nanomaterials (Basel). 2021 Oct 21;11(11):2790. doi: 10.3390/nano11112790. Nanomaterials (Basel). 2021. PMID: 34835553 Free PMC article. Review.

10

Retraction Notice to: Schizandrin A Protects Human Retinal Pigment Epithelial Cell Line ARPE-19 against HG-Induced Cell Injury by Regulation of miR-145.

Dong Y, Qian C, Wan G, Yan P, Liang S, Wang J. Dong Y, et al. Among authors: liang s. Mol Ther Oncolytics. 2022 May 10;25:262. doi: 10.1016/j.omto.2022.05.001. eCollection 2022 Jun 16. Mol Ther Oncolytics. 2022. PMID: 35615264 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results